Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …
The Real-Time Rep Defined The Real-Time Rep, no longer a fictitious ideal, is a salesperson who is able to:
Over the last two decades technology has allowed companies to greatly increase their global reach. Within the pharmaceutical sector it …
Pulsar have done very well of late and managed to bag 1 silver Rx award and 6 New York Rx …
The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …
Clinical research is rapidly moving toward the electronic environment as more han half of all studies are conducted utilizing EDC, …
Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …
December 23, 2010 [Taoyuan, Taiwan]: With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under …
by Francis Namouk, Streaming Well
This article was originally published by PharmaPhorum in Spring 2010.
Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
by Kathryn Bennett, Managing Director – TVF Communications
Some consider it just another channel to market, but the reality is more complicated.by Mark Millar, PraeMedica
by Matthew Baker, Deputy Managing Director – LEC